GlassScriptPhysician profile
Brajesh Kumar Agrawal
NPI 1326269515
$2,822.94
in general payments reported to CMS, 2019-2025
11 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $353 · 2021: $12.85 · 2022: $1,318 · 2023: $287 · 2024: $124 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Medical Corporation | $956.42 | 2022 | |
| Dr.Reddy'S Laboratories,INC. | $379.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $349.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $333.00 | 2020 | |
| Sk Life Science, INC. | $248.97 | 2023-2025 | Xcopri |
| Boston Scientific Corporation | $222.98 | 2019 | |
| Eisai INC. | $163.78 | 2023-2024 | |
| Cala Health, INC. | $105.83 | 2023 | Cala Trio |
| Nevro Corp. | $38.95 | 2020-2023 | Senza |
| Novartis Pharmaceuticals Corporation | $12.85 | 2021 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brajesh Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.